Managing constipation whilst on GLP-1 treatments Dietary strategies Increase fibre intake gradually to 25-30g daily through fruits, vegetables, whole grains, and legumes Stay well-hydrated with at least 2-3 litres of water daily Consider psyllium husk or other soluble fibre supplements if dietary fibre is insufficient Magnesium supplements can have a laxative effect and relieve constipation Include probiotic-rich foods like yoghurt, kefir and fermented vegetables Limit foods that may worsen constipation such as processed foods, cheese, and white bread Physical activity approaches Try specific yoga poses known to stimulate digestive motility Practice abdominal massage in a clockwise direction Maintain an active lifestyle with regular movement throughout the day and at least 30 minutes regular exercise Consider a short walk after meals to stimulate digestion Bathroom habits Establish a regular toileting routine at the same time each day Dont ignore the urge to have a bowel movement Use proper positioning with knees higher than hips (a footstool can help) Allow sufficient unhurried time in the bathroom Practice relaxation techniques to reduce tension during bowel movements Medical interventions Over-the-counter osmotic laxatives like polyethylene glycol (Movicol) for occasional relief Stool softeners such as docusate sodium (Dioctyl) if stools are particularly hard Bulk-forming laxatives such as ispaghula husk (Fybogel)

Thiamine (Vitamin B1): Converts carbohydrates into energy Super Lipo-B/Lido Injections: Key Ingredients & Benefits: Ascorbic Acid (Vitamin C) : Speeds up metabolism and helps burn more calories
Even in the U.S. pricey prescription drug market Americans pay some of the highest costs for medications in the world GLP-1s are notably expensive: Annual list prices for the drugs can exceed $11,000
These combined effects make Retatrutide one of the most promising potential treatments for obesity and metabolic disease
These include removal of uterus, cervix, lymph nodes, menstrual changes, swollen legs, hair loss, change in periods, increased infections, changes in the cervix, blood clots or bleeding [1923]
Three categories of GLP-1 analogs, are being developed and/or are in clinical use: short-acting, long-acting, and prolonged-acting GLP-1 analogs